Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Oct 2026 for AgomAb Therapeutics NV, €45k. Read the official filing
Filing timeline
BuySaleTim Jasper Knotnerus
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Tim Jasper Knotnerus: trading record in brief
Tim Jasper Knotnerus discloses dealings in AgomAb Therapeutics NV to SEC (Form 4). We count 2 filings; the first trade dates from 5 October 2026 and the latest from 6 October 2026.
The open-market record is one-sided, with 2 purchases worth €84k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 7 October 2026 came the latest disclosure, an open-market purchase for €45k in AgomAb Therapeutics NV. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tim Jasper Knotnerus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6,000 shares@ US$8.48Common sharesSEC:0002120886-26-000001:0
Canonical exit: 3 Jan 2027 (T+90)
5,000 shares@ US$8.70Common sharesSEC:0002120886-26-000001:1
Canonical exit: 4 Jan 2027 (T+90)
2 of 2 declarations
